SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021878
Filing Date
2020-08-13
Accepted
2020-08-13 16:13:54
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_hoththerapeutics.htm 10-Q 499715
2 LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF CINCINNATI AND CHELEXA BIOSCI f10q0620ex10-3_hoththerap.htm EX-10.3 87905
3 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF f10q0620ex10-4_hoththerap.htm EX-10.4 9909
4 SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF f10q0620ex10-5_hoththerap.htm EX-10.5 8687
5 ASSIGNMENT AND ASSUMPTION AGREEMENT BY AND BETWEEN THE COMPANY AND CHELEXA BIOSC f10q0620ex10-6_hoththerap.htm EX-10.6 46394
6 ROYALTY AGREEMENT BY AND BETWEEN THE COMPANY AND CHELEXA BIOSCIENCES, INC. DATED f10q0620ex10-7_hoththerap.htm EX-10.7 56037
7 NOVATION AGREEMENT BY AND AMONG THE COMPANY, CHELEXA BIOSCIENCES, INC. AND THE U f10q0620ex10-8_hoththerap.htm EX-10.8 12150
8 PATENT LICENSE AGREEMENT BY AND BETWEEN THE COMPANY AND THE GEORGE WASHINGTON UN f10q0620ex10-9_hoththerap.htm EX-10.9 178470
9 CERTIFICATION f10q0620ex31-1_hoththerap.htm EX-31.1 13554
10 CERTIFICATION f10q0620ex31-2_hoththerap.htm EX-31.2 13560
11 CERTIFICATION f10q0620ex32-1_hoththerap.htm EX-32.1 5017
12 CERTIFICATION f10q0620ex32-2_hoththerap.htm EX-32.2 5075
19 GRAPHIC ex10-9_001.jpg GRAPHIC 56678
  Complete submission text file 0001213900-20-021878.txt   3297487

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE hoth-20200630.xml EX-101.INS 408324
14 XBRL SCHEMA FILE hoth-20200630.xsd EX-101.SCH 45459
15 XBRL CALCULATION FILE hoth-20200630_cal.xml EX-101.CAL 38848
16 XBRL DEFINITION FILE hoth-20200630_def.xml EX-101.DEF 163761
17 XBRL LABEL FILE hoth-20200630_lab.xml EX-101.LAB 270924
18 XBRL PRESENTATION FILE hoth-20200630_pre.xml EX-101.PRE 224437
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 201099478
SIC: 2834 Pharmaceutical Preparations